Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT

References

• Michalski JM, Gay H, Jackson A, et al. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76:S123–S129.
   PubMed Web of Science ®Google Scholar
• Acosta O, Drean G, Ospina JD, et al. Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy. Phys Med Biol. 2013;58:2581–2595.
   PubMed Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, et al. Using dose-surface maps to predict radiation-induced rectal bleeding: a neural network approach. Phys Med Biol. 2009;54:5139–5153.
   PubMed Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, et al. Modeling late rectal toxicities based on a parameterized representation of the 3d dose distribution. Phys Med Biol. 2011;56:2103–2118.
   PubMed Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, et al. Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the mrc rt01 trial (isrctn 47772397). Phys Med Biol. 2009;54:6535–6548.
   PubMed Web of Science ®Google Scholar
• Buettner F, Gulliford SL, Webb S, et al. The dose-response of the anal sphincter region-an analysis of data from the MRC RT01 trial. Radiother Oncol. 2012;103:347–352.
   PubMed Web of Science ®Google Scholar
• Casares-Magaz O, Muren LP, Moiseenko V, et al. Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer. Acta Oncol. 2017;56:1507–1513.
   PubMed Web of Science ®Google Scholar
• Gianolini S, Widesott L, Rancati T, et al. Does the shape of the rectal surface dose distribution predict the risk of late rectal incontinence and bleeding, in patients treated with high-dose 3dcrt for localized prostate cancer? Radiother Oncol. 2008;88:S320.
   Web of Science ®Google Scholar
• Hoogeman MS, van Herk M, de Bois J, et al. Quantification of local rectal wall displacements by virtual rectum unfolding. Radiother Oncol. 2004;70:21–30.
   PubMed Web of Science ®Google Scholar
• Lee R, Chan EK, Kosztyla R, et al. Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate external-beam radiotherapy. Phys Med Biol. 2012;57:8297–8307.
   PubMed Web of Science ®Google Scholar
• Munbodh R, Jackson A. Quantifying cell migration distance as a contributing factor to the development of rectal toxicity after prostate radiotherapy. Med Phys. 2014;41:021724.
   PubMed Web of Science ®Google Scholar
• Munbodh R, Jackson A, Bauer J, et al. Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer. Med Phys. 2008;35:2137–2150.
   PubMed Web of Science ®Google Scholar
• Sanchez-Nieto B, Fenwick JF, Nahum AE, et al. Biological dose surface maps: evaluation of 3d dose data fortubular organs. Radiother Oncol. 2001;61:S52.
   Google Scholar
• Shelley LEA, Scaife JE, Romanchikova M, et al. Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy. Radiother Oncol. 2017;123:466–471.
   PubMed Web of Science ®Google Scholar
• Tucker SL, Zhang M, Dong L, et al. Cluster model analysis of late rectal bleeding after imrt of prostate cancer: a case-control study. Int J Radiat Oncol Biol Phys. 2006;64:1255–1264.
   PubMed Web of Science ®Google Scholar
• van Lin EN, Hoffmann AL, van Kollenburg P, et al. Rectal wall sparing effect of three different endorectal balloons in 3d conformal and imrt prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:565–576.
   PubMed Web of Science ®Google Scholar
• Wortel RC, Witte MG, van der Heide UA, et al. Dose-surface maps identifying local dose-effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer. Radiother Oncol. 2015;117:515–520.
   PubMed Web of Science ®Google Scholar
• Fonteyne V, Sadeghi S, Ost P, et al. Impact of changing rectal dose volume parameters over time on late rectal and urinary toxicity after high-dose intensity-modulated radiotherapy for prostate cancer: a 10-years single centre experience. Acta Oncol. 2015;54:854–861.
   PubMed Web of Science ®Google Scholar
• Fellin F, Azzeroni R, Maggio A, et al. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison. Radiother Oncol. 2013;107:207–212.
   PubMed Web of Science ®Google Scholar
• van Wijk Y, Vanneste BL, Jochems A, et al. Development of an isotoxic decision support system integrating genetic markers of toxicity for the implantation of a rectum spacer. Acta Oncol. 2018;57:1499–1505.
   PubMed Web of Science ®Google Scholar
• Heemsbergen WD, Al-Mamgani A, Witte MG, et al. Urinary obstruction in prostate cancer patients from the dutch trial (68 gy vs. 78 gy): relationships with local dose, acute effects, and baseline characteristics. Int J Radiat Oncol Biol Phys.2010;78:19–25.
   PubMed Web of Science ®Google Scholar
• Palorini F, Cozzarini C, Gianolini S, et al. First application of a pixel-wise analysis on bladder dose-surface maps in prostate cancer radiotherapy. Radiother Oncol. 2016;119:123–128.
   PubMed Web of Science ®Google Scholar
• Cozzarini C, Rancati T, Carillo V, et al. Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: results of a cohort study. Radiother Oncol. 2015;116:185–191.
   PubMed Web of Science ®Google Scholar
• Cozzarini C, Rancati T, Palorini F, et al. Patient-reported urinary incontinence after radiotherapy for prostate cancer: quantifying the dose-effect. Radiother Oncol. 2017;125:101–106.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Fellin G, Rancati T, et al. Clinical and dosimetric predictors of late rectal syndrome after 3d-crt for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys. 2008;70:1130–1137.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Rancati T, Fellin G, et al. Late fecal incontinence after high-dose radiotherapy for prostate cancer: better prediction using longitudinal definitions. Int J Radiat Oncol Biol Phys. 2012;83:38–45.
   PubMed Web of Science ®Google Scholar
• Rancati T, Fiorino C, Fellin G, et al. Inclusion of clinical risk factors into ntcp modelling of late rectal toxicity after high dose radiotherapy for prostate cancer. Radiother Oncol. 2011;100:124–130.
   PubMed Web of Science ®Google Scholar
• Chen C, Witte M, Heemsbergen W, et al. Multiple comparisons permutation test for image based data mining in radiotherapy. Radiat Oncol. 2013;8:293.
   PubMed Web of Science ®Google Scholar
• Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res. 1985;104:7.
   Web of Science ®Google Scholar
• Gulliford SL, Partridge M, Sydes MR, et al. A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity. Radiother Oncol. 2010;94:241–247.
   PubMed Web of Science ®Google Scholar
• Fiorino C, Valdagni R, Rancati T, et al. Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol. 2009;93:153–167.
   PubMed Web of Science ®Google Scholar
• Landoni V, Fiorino C, Cozzarini C, et al. Predicting toxicity in radiotherapy for prostate cancer. Phys Med. 2016;32:521–532.
   PubMed Web of Science ®Google Scholar
• Sander L, Langkilde NC, Holmberg M, et al. MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol. 2014;53:809–814.
   PubMed Web of Science ®Google Scholar
• Onjukka E, Rintelä N, Castellanos E, et al. Does prostate radiation therapy treatment planning benefit from MRI? Int J Radiat Oncol Biol Phys. 2015;93:E569.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, Heemsbergen WD, Peeters ST, et al. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73:685–691.
   PubMed Web of Science ®Google Scholar
• Cicchetti A, Avuzzi B, Rancati T, et al. Predicting late faecal incontinence risk after rt for prostate cancer: new insights from external independent validation. Int J Radiat Oncol Biol Phys. 2018;102:127–136.
   PubMed Web of Science ®Google Scholar
• Wortel RC, Incrocci L, Pos FJ, et al. Late side effects after image guided intensity modulated radiation therapy compared to 3d-conformal radiation therapy for prostate cancer: results from 2 prospective cohorts. Int J Radiat Oncol Biol Phys. 2016;95:680–689.
   PubMed Web of Science ®Google Scholar
• Kim DWN, Cho LC, Straka C, et al. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014;89:509–517.
   PubMed Web of Science ®Google Scholar
• Scaife JE, Thomas SJ, Harrison K, et al. Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancer. Br J Radiol. 2015;88:20150243.
   PubMed Web of Science ®Google Scholar
• Rutkowska E, Baker C, Nahum A. Mechanistic simulation of normal-tissue damage in radiotherapy-implications for dose-volume analyses. Phys Med Biol. 2010;55:2121–2136.
   PubMed Web of Science ®Google Scholar
• Improta I, Palorini F, Cozzarini C, et al. Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer. Phys Med. 2016;32:1681–1689.
   PubMed Web of Science ®Google Scholar
• Yahya N, Ebert MA, House MJ, et al. Modeling urinary dysfunction after external beam radiation therapy of the prostate using bladder dose-surface maps: evidence of spatially variable response of the bladder surface. Int J Radiat Oncol Biol Phys. 2017;97:420–426.
   PubMed Web of Science ®Google Scholar